-When activated muscle fibers are stretched, there is a long-lasting increase in the force. This phenomenon, referred to as "residual force enhancement," has characteristics similar to those of the "static tension," a long-lasting increase in force observed when muscles are stretched in the presence of Ca 2ϩ but in the absence of myosin-actin interaction. Independent studies have suggested that these two phenomena have a common mechanism and are caused either by 1) a Ca 2ϩ -induced stiffening of titin or by 2) promoting titin binding to actin. In this study, we performed two sets of experiments in which activated fibers (pCa 2ϩ 4.5) treated with the myosin inhibitor blebbistatin were stretched from 2.7 to 2.8 m at a speed of 40 Lo/s, first, after partial extraction of TnC, which inhibits myosin-actin interactions, or, second, after treatment with gelsolin, which leads to the depletion of thin (actin) filaments. We observed that the static tension, directly related with the residual force enhancement, was not changed after treatments that inhibit myosin-actin interactions or that deplete fibers from troponin C and actin filaments. The results suggest that the residual force enhancement is caused by a stiffening of titin upon muscle activation but not with titin binding to actin. This finding indicates the existence of a Ca 2ϩ -regulated, titin-based stiffness in skeletal muscles.
titin; myosin-actin; blebbistatin; sarcomere; cross-bridges THERE IS EVIDENCE that skeletal muscles contain a cross-bridge independent component that increases the sarcomere stiffness upon activation. Such component is obvious in studies showing that, when activated muscle fibers are stretched in conditions where myosin-actin interaction is inhibited, there is an increase in the force that is regulated by Ca 2ϩ concentration (2, 4) . The increase in force persists for as long as activation continues; this force component has been referred to as "static tension." Since myosin and actin are not associated with the static tension, this form of force regulation is potentially controlled by passive structures within the sarcomeres. Interestingly, the length-dependent and velocity-dependent characteristics of the "static tension" are very similar to the "residual force enhancement" [e.g., (6, 25, 28) ; for a review see Ref. 12] ; an increase in active force observed after muscles are stretched upon activation, a phenomenon observed for more than 50 years (1) but with mechanisms that are still elusive. Thus it is possible that the two phenomena are related and caused by similar mechanisms.
The static tension and the residual force enhancement may be caused by titin, the sarcomeric structure responsible for most of the passive forces in striated muscles (2, 4, 19, 25) , which would change its characteristic upon muscle activation. There are potentially two mechanisms by which titin could be regulated by Ca 2ϩ . First, elevated Ca 2ϩ concentrations could increase the stiffness of the Pro-Glu-Val-Lys (PEVK) element of titin as a result of Ca 2ϩ binding to the glutamate-rich PEVK region of the molecule. This mechanism leads to a decrease in the persistence length of titin (18) and thus a potential increase in stiffness and passive force production. Second, a Ca 2ϩ -dependent increase in the binding of titin with actin could increase the sarcomere stiffness. It has been suggested that the Ca 2ϩ -induced increase in titin-actin binding could be caused by conformational changes in regulatory proteins (troponin and tropomyosin) or by stretching of the actin filaments; both would open actin binding sites for titin (19) . Early studies have shown that titin inhibits the sliding of the actin filaments when tested with in vitro motility essays in the presence of Ca 2ϩ , suggesting that titin binding to actin increases (15) . However, subsequent studies failed to detect binding between the tandem Ig segments of titin and actin (17, 35) ; one study in fact reported a reduction in the titin-actin interactions in the presence of Ca 2ϩ (32) . Therefore, the mechanism by which Ca 2ϩ activation influences the properties of titin and passive force regulation remains elusive. In this study, we reevaluated the passive force regulation by Ca 2ϩ using permeabilized fibers from rabbit psoas muscles. We observed the presence of a static tension, directly correlated to the residual force enhancement, which was maintained when myosin-actin interaction was inhibited by troponin C (TnC) depletion and actin filament extraction. The results suggest that this form of passive force regulation is caused by stiffening of titin and not by an increase in titin-actin binding. Such mechanism may represent an important form of force regulation in skeletal muscles not deeply investigated to date.
METHODS
Preparation of muscle fibers. Small muscle bundles of the rabbit psoas were dissected, tied to wood sticks, and chemically permeabilized following standard procedures (5, 21) . Muscles were incubated in rigor solution (pH ϭ 7.0) for ϳ4 h, after which they were transferred to a rigor-glycerol (50:50) solution for 15 h. The samples were subsequently placed in a fresh rigor-glycerol (50:50) solution with the addition of a cocktail of protease inhibitors (Roche Diagnostics) and stored in a freezer (Ϫ20°C) for at least 7 days. The protocol was approved by the McGill University Animal Care Committee and complied with the guidelines of the Canadian Council on Animal Care.
On the day of the experiment, a muscle sample was transferred to a fresh rigor solution and stored in the fridge for 1 h before use. A small section of the sample was cut (ϳ4 mm in length), and single fibers were carefully dissected in relaxing solution (see Solutions).
The fibers were gripped at their ends with T-shaped clips made of aluminum foil and were transferred to a temperature-controlled chamber to be attached between a force transducer (resonant frequency 1 kHz; model 403A, Aurora Scientific, Toronto, Canada) and a length controller (model 312B, Aurora Scientific).
Solutions. The rigor solution (pH 7.0) was composed of the following (in mM): 50 Tris, 100 NaCl, 2 KCl, 2 MgCl 2, and 10 EGTA. The relaxing solution used for muscle storage and dissection (pH 7.0) was composed of (in mM) 100 KCl, 2 EGTA, 20 imidazole, 4 The active form (ϩ/Ϫ) of blebbistatin (Sigma-Aldrich) was dissolved in dimethylformamide to reach a concentration of 20 mM and was stored at Ϫ20C o before use. On the day of the experiment, 1 l of blebbistatin was diluted in 1 ml of activating (pCa 2ϩ 4.5) or relaxing (pCa 2ϩ 9.0) solutions to reach a final concentration of 20 M. A previous study performed in our laboratory tested both the active (ϩ/Ϫ) and inactive (ϩ/ϩ) isomers of blebbistatin and showed that the active isomer inhibits force production while the inactive isomer does not affect significantly the contractile properties of the rabbit psoas (21) . Throughout the experiments, the microscope room was maintained dark and a red filter (650 nm) was placed on the light source of the microscope because blebbistatin (ϩ/Ϫ) loses its effectiveness when exposed to wavelengths between 365 and 490 nm (16) .
Experimental protocol. Before the start of each experiment, the average sarcomere length (SL) was measured in relaxing solution using a high-speed video system (HVSL, Aurora Scientific 901A). Images from a selected region of the fibers were used to calculate SL by fast Fourier transform (FFT) analysis based on the striation spacing produced by dark and light bands of myosin and actin, respectively. The fiber diameter and length were measured using a CCD camera (Go-3, QImaging; pixel size: 3.2 m ϫ 3.2 m), and the crosssectional area was estimated assuming circular symmetry.
In total, 14 fibers were used for this study. Two separate sets of experiments were performed using 1) fibers that were activated in pCa 2ϩ 4.5 before and after extraction of TnC and treated with blebbistatin (ϩ/Ϫ) (all fibers, n ϭ 14); and 2) fibers that were activated in pCa 2ϩ 4.5 before and after extraction of TnC and actin and treated with blebbistatin (ϩ/Ϫ) (n ϭ 7). All experiments were performed at 8°C. Figure 1 shows pictures taken from one fiber after the different treatments used in this study. Note that the striation pattern and general structure of the fibers did not change significantly with any of the treatments, which allowed consistent measurements of force and SL throughout the experiments.
For the first set of experiments, fibers were activated isometrically (pCa 2ϩ 4.5) at SL of 2.5, 2.7, and 2.8 m. Then they were stretched passively (pCa 2ϩ 9.0) from 2.7 to 2.8 m. Finally, they were activated at 2.7 m, and when force was fully developed (pCa 2ϩ 4.5), a ramp stretch of ϳ4% Lo was applied to the fibers, with velocity 40 Lo·SL·s Ϫ1 . Before and after the stretch, quick step stretches of 0.3% Lo were applied to the fibers for measurements of stiffness (K), calculated as ⌬force/⌬length during the step.
After mechanical testing was completed, the fibers were treated for extraction of TnC according to a standard protocol (10, 13, 22, 23, 26) . Briefly, fibers were set at an average SL of 2.8 m and incubated for 90 min in rigor-EDTA solution (pH 8.5) composed of 5 mM EDTA and rigor solution at 8°C. The timing for the extraction procedure differed slightly from previous studies, but it was determined after pilot experiments (n ϭ 6); the force decreased to ϳ40% of the initial isometric force and did not decrease further after 90 min. After TnC extraction, the isometric force (pCa 2ϩ 4.5) was measured in SL ϳ2.5 m. The fibers were then activated (pCa 2ϩ 4.5) in the presence of blebbistatin (ϩ/Ϫ) following the same protocol as described above: isometric contractions at 2.5, 2.7, and 2.8 m and stretches from 2.7 to 2.8 m in relaxing (pCa 2ϩ 9.0) and activating (pCa 2ϩ 4.5) solutions. For the second set of experiments, fibers underwent the same protocol as previously described, and subsequently they were treated with FX45 gelsolin fragment for extraction of actin filaments. Briefly, the fibers were bathed in solution (pH 7.0) containing 20 mM BDM, activation solution (pCa 2ϩ 4.5), and 2 g gelsolin (Sigma-Aldrich) at 8°C for 20 min and subsequently washed with relaxing solution for 5 min. The fibers were subsequently treated with blebbistatin (ϩ/Ϫ) and the entire mechanical protocol was repeated.
After the two protocols were performed, the fibers were set at an initial SL of 2.7 m and were stretched in consecutive steps of 5% L o with intervals of 20 s between stretches. The protocol was developed in pCa 2ϩ 9.0 and pCa 2ϩ 4.5 and was intended for comparisons of the passive force-SL relation in the two Ca 2ϩ concentrations. At the end of all experiments, the fibers were frozen for subsequent analysis of protein content. After tissue preparation following standard procedures, the samples were transferred into microfluidic chips (Experion Pro260, Caliper Sciences) built with small semiconductors. The microchips were introduced into an automated electrophoresis system (Experion, Bio-Rad). The samples within each microchip are electrokinetically injected through separation channels, inside which the samples are illuminated by a laser for measurements of fluorescence intensity; the areas under the fluorescence peaks are calculated to provide the concentration and molecular weight of the proteins. We were interested mostly to confirm that our treatment was successful in Fig. 1 . Photographs taken from a fiber in the experimental chamber during a typical experiment before treatment (control) (A); after rigor-EDTA treatment (B); after rigor-EDTA and blebbistatin (ϩ/Ϫ) treatment (C); and after rigor-EDTA, gelsolin, and blebbistatin (ϩ/Ϫ) treatment (D). The striation pattern and structure of the fiber are maintained after the different treatments. The red color in the bottom pictures are due to the red filter (650 nm) used in experiments with blebbistatin (ϩ/Ϫ).
partially extracting TnC and actin filaments and thus only used fibers with TnC depleted by at least 50% of its total content (actual range observed in the data presented in this paper: 52-58%) and fibers with actin depleted by at least 90% of its total content (actual range observed in the data presented in this paper: 91-96%). The variability of the results was very high, which makes direct relation between proteins content and mechanical results difficult to interpret, but these fibers were always treated with blebbistatin (ϩ/Ϫ) before mechanical experimentation to avoid remaining myosin-actin interaction, ensuring that contractile proteins were not active.
Data analysis. The residual force enhancement was calculated as the difference of force produced after an active stretch (from 2.7 to 2.8 m) compared with the force produced during the isometric contraction at the corresponding final length (2.8 m). The static tension was calculated as the force produced after the active stretch (from 2.7 to 2.8 m) subtracted from the passive stretch (from 2.7 to 2.8 m) and the isometric force produced at the corresponding length (2.8 m). All forces were measured 2 s before deactivation of the fibers, where the force decay just following stretch had vanished and the force was stabilized in a steady state. All comparisons of forces and stiffness between contractions were performed using analysis of variance (ANOVA) for repeated measures. When significant changes were observed, post hoc analyses were performed with Newman-Keuls tests (P Ͻ 0.05). All results are shown as means Ϯ SE. All static tension results were evaluated with the Kolmogorov-Smirnov test for normality of the data, and the results were satisfactory: the maximum cumulative distance between the histogram of the static tension data and its Gaussian distribution never exceeded 0.189 (P Ͻ 0.05). Since the static tension is one of the major outcomes of this study, we calculated the power of our smallest sample (n ϭ 7) for the ANOVA comparisons, and the result was satisfactory (power ϭ 0.887). All statistical analyses were performed with software SigmaStat 3.5 (Systat Software). Figure 2A shows contractions produced in a SL of 2.5 m by a fiber that underwent different treatments used in this study. The force produced in control solution (pCa 2ϩ 4.5) is well within the range observed in other studies performed at low temperatures (5, 21) . Note that at this condition there was significant shortening of the fiber during full activation (as seen in the SL traces), in this case ϳ0.3 m, but after full force development the average SL was virtually unchanged; i.e., an isometric contraction was produced. In this example, treatment with rigor-EDTA, which depletes the fibers from TnC, decreased the force by 48%. The force decrease Fig. 2 . A: isometric contractions recorded during a typical experiment showing the effects of different treatments on force production. Changes in solution during activation and relaxation create noise in the system, which is reflected in the force transducer and also in the images collected by the camera for sarcomere length (SL) measurements, but it quickly dissipates. After rigor-EDTA, gelsolin, and blebbistatin (ϩ/Ϫ) treatments, there was not active force production. The decrease in force was associated with a decrease in stiffness, measured in two different moments during these contractions by imposing a quick stretch (arrow). SL changes are depicted in the bottom panel; note that there is very little shortening during activations of fibers after inhibition of myosinactin interactions. B: means (ϮSE) values for force and stiffness measured during isometric contractions at 2.5 m in the different conditions investigated in this study. 1: control, 2: rigor-EDTA, 3: rigor-EDTA ϩ blebbistatin (ϩ/Ϫ), 4: rigor-EDTA ϩ gelsolin ϩ blebbistatin (ϩ/Ϫ).
RESULTS

Effect of treatments.
with rigor-EDTA is within the range observed in previous studies (22, 23) . Although the values seem to be highly dependent on the experimental condition, the variability in the isometric forces produced after treatment is small among fibers, conferring a high reproducibility to our results. Of importance for this study, further incubation of the fibers with blebbistatin (ϩ/Ϫ) decreased the force to 7% of the maximal isometric force. Treatment with gelsolin, which depletes the fibers from thin filaments, and blebbistatin (ϩ/Ϫ) completely inhibited force production in this fiber. Note that the contractions produced after the different force inhibitors showed much lower amounts of sarcomere shortening. Mean (ϮSE) values (Fig. 2B) for all the experiments performed in this study confirm the results presented in Fig. 2A . Force decreased significantly after partial extraction of TnC and actin (F ϭ 94.919, P Ͻ 0.001). The inhibition of force occurred parallel to a decrease in stiffness during the isometric contractions (F ϭ 119.20, P Ͻ 0.001). Figure 3 shows force traces recorded during a typical experiment performed with a fiber in this study. The figure shows isometric contractions produced at 2.7 and 2.8 m and two stretches that were initiated at 2.7 m: a passive (P) and an active (A) stretch. In the latest, the fiber was initially activated (pCa 2ϩ 4.5), and after full force development, it was stretched. During the stretch, the force rose considerably, and after the end of stretch the force decreased slowly until a steady-state level was obtained, after which the fiber was deactivated. The steady-state force after the stretch was higher than that produced during the isometric contraction at the corresponding length; i.e., residual force enhancement was observed. The passive force during the stretch was negligible in this example. When all experiments were grouped, the level of force enhancement was 7.28 Ϯ 1.89%. Stiffness measurements before and after the stretch are also shown in this graph; in this case the stiffness after stretch was increased compared with the isometric contraction produced at the corresponding length. Figure 4 shows contractions recorded during the same experiment as in Fig. 2 but after the fiber had been treated with rigor-EDTA and blebbistatin (ϩ/Ϫ). Note the significant decrease in force produced during the isometric contraction. Similarly to the previous example, the fiber was initially activated in pCa 2ϩ of 4.5 at ϳ2.7 m and stretched after full force development. When normalized for the initial isometric force, the increase in force during stretch was significantly higher than in the previous example shown in Fig. 3 (before treatment). The residual force enhancement was still present in this fiber. When normalized for the isometric force at a corresponding length, it was higher than before treatment. The force produced after the active stretch was also higher than that produced during the passive stretch. Figure 5 shows contractions recorded during the same experiment as in Fig. 4 but this time after gelsolin treatment. The Fig. 4 . Superimposed contractions produced by the same fiber shown in Fig. 3 , following the same experimental protocol, but after treatment with rigor-EDTA and blebbistatin (ϩ/Ϫ). The isometric force was substantially decreased after the treatment, but during the active stretch (line A) the force increased substantially to then decrease and attain a steady state, considerably higher than the force obtained during isometric contractions and after the passive stretch (line P). The thick bar in the top of the graph shows a period after stretch in which force was stabilized and was higher than the purely isometric force. SL changes are depicted in the bottom panel. . The figure also shows the passive stretch (line P) conducted with similar characteristics, which produced a very small force. During the active stretch, the force increased substantially, and after the stretch the force decreased to attain a steady-state that was higher than the force obtained during isometric the contractions. The thick bar in the top of the graph shows a period after stretch in which force was stabilized and was higher than the purely isometric force. The final sarcomere after stretches corresponds with the isometric contractions produced at 2.8 m. The stiffness measurements before and after stretch are also shown; the stiffness after stretch was higher than the stiffness produced during the corresponding isometric contraction. Inset, a zoomed image of the force traces during stiffness measurements after the stretch (A) and during an isometric contraction (2.8 m). In this case, the traces were offset by 18 ms for a clearer visualization. SL changes are depicted in the bottom panel.
results are similar to those presented after partial TnC extraction; an elevated increase in force during stretch and residual force enhancement, in similar levels of those observed after the rigor-EDTA treatment. The results of stiffness observed in the previous graphs were all confirmed statistically (Fig. 6) . A small but significant increase was observed after stretch compared with isometric contractions in any of the conditions investigated in this study. The stiffness decreased significantly after rigor-EDTA treatment and gelsolin treatments in all lengths, but it increased after the stretch even when myosinactin interaction was not present.
We calculated the static tension in our experiments by subtracting the force produced during an isometric contraction and the force produced after a passive stretch from the total force produced after an active stretch. In Fig. 7A we show traces obtained after such calculation. We overlapped the graphs shown in previous figures for comparisons. Before treatments, the level of static tension was 3.58 Ϯ 1.96% above the forces obtained at the corresponding, final length. Although the absolute force produced during the stretch was lowered after rigor-EDTA and gelsolin treatments, the static tension was maintained. There was a strong relationship between the levels of residual force enhancement and the degree of static tension (Fig. 7B) . Note that in three cases there was no force enhancement and static tension was not observed. Figure 7C shows boxplots (95% confidence interval) constructed with the values obtained for the static tension for the three main conditions investigated in this study. There was not a statistical difference between the static tension measured before treatments, after rigor-EDTA ϩ blebbistatin treatment, or after EDTA-rigor ϩ blebbistatin ϩ gelsolin treatment (F ϭ 1.086, P ϭ 0.369) (Fig. 7C) . Since the static tension showed different degrees of variability during the experiments, we performed an F test to compare the data variance among the three conditions (see Fig. 7C, inset) . The variances were different (F ϭ 4.366, P ϭ 0.028), and post hoc analysis showed that it was higher before treatments than after treatments with rigor-EDTA ϩ blebbistatin and EDTA-rigor ϩ blebbistatin ϩ gelsolin. However, the variance was not different between the two treatment conditions (P ϭ 0.591, Newman-Keuls test). Figure 8A shows the passive-force SL relation for one typical fiber investigated in this study, before and after treatment with rigor-EDTA, gelsolin, and blebbistatin (ϩ/Ϫ). Note that the peak forces during the stretches and the passive forces after stretch increase in the presence of Ca 2ϩ . The result was confirmed with all fibers tested in this study, presenting a passive force-SL curve that is typical for skeletal muscles (Fig. 8B ).
DISCUSSION
The main findings of this study were that 1) a static tension, directly related to the residual force enhancement, is present in permeabilized fibers from psoas muscles before and after inhibition of myosin-actin interaction; 2) the static tension and the force enhancement are not caused by Ca 2ϩ -induced changes in TnC; and 3) the static tension and the force enhancement are not caused by an increase in titin-actin binding. These results suggest that the mechanism responsible for the static tension and residual force enhancement is associated with a non-cross-bridge structure, most likely an increase in the stiffness of titin. The isometric force was substantially decreased after treatments, but during the active stretch the force still increased substantially. The steady-state force obtained after an active stretch (line A) was maintained higher than the force obtained during isometric contractions and after the passive stretch (line P). The thick bar in the top of the graph shows a period after stretch in which force was stabilized and was higher than the purely isometric force. SL changes are depicted in the bottom panel.
The level of residual force enhancement of 7.28% P o that we observed in our study is within the lower range observed in the literature, but comparisons among studies are not trivial. The level of force enhancement is highly dependent on the experimental conditions, including temperature, species (amphibians, mammalians), and preparation (single fibers, whole muscles). We are not aware of similar analyses made with permeabilized muscle fibers from the psoas, but the results were consistently repeated through the study. The static tension, not as commonly investigated in other studies, was 3.58% P o at SL of 2.8 m (before treatments), comparable with studies of Bagni and colleagues (3, 4) , who reported similar levels when single fibers from amphibians were stretched by ϳ30 nm/halfsarcomere. In our study, the stretch was ϳ50 nm/half-sarcomere, but we calculated the static tension by subtracting the active force obtained at the final, corresponding length after stretch (in this case 2.8 m). When we calculate the static tension subtracting the isometric force at the initial length (2.7 m), the static tension was 1.57% P o .
The residual force enhancement and static tension was accompanied by a small, but significant, increase in stiffness after stretch. Although a previous study has reported an increase in stiffness after stretch of intact fibers for the frog (29), two other studies suggested that fiber stiffness in the forceenhanced state was not substantially different from that observed during isometric, reference contractions (14, 33) . It is not obvious why apparently similar experiments should give conflicting results, but interpretation of stiffness results requires caution. Stiffness reflects both the proportion of attached cross bridges and the cross-bridge attachment distribution (8, 9) , but most importantly for this study, also non-cross-bridge compliant structures present in the fibers (3, 4, 8, 9 ). Since we stretched muscle fibers in a range where passive forces start to play a role in the psoas muscles, our results may be directly associated with passive structures. The results that we observed after partial extraction of TnC, actin, and blebbistatin (ϩ/Ϫ) treatment strengthen this hypothesis, as the increase in stiffness after stretch was maintained in the absence of myosin-actin interactions. Since the relevant stiffness comparisons in the present study were made between isometric reference contractions and the corresponding stretch contractions, we suggest that the increase in stiffness is caused by non-cross-bridge structures, and more specifically, by titin molecules.
It has been suggested previously that titin may be responsible for the residual force enhancement (13, 19, 27, 30) and the static tension (3, 4) . Accordingly, titin would change its mechanical properties upon muscle activation (2, 4, 19, 20, 25,  27) . Conceptually, titin could regulate force in response to increasing Ca 2ϩ concentrations in two ways. During activation, an increase in Ca 2ϩ concentrations can increase the stiffness of the PEVK element of titin as a result of binding to the glutamate-rich PEVK region of the molecule. This mechanism leads to a decrease the persistence length of titin (18) and thus a potential increase in stiffness and passive force production. In that case, the only necessary mechanism responsible for the titin-induced increase in force is Ca 2ϩ binding to titin (18) , without further linkage with other proteins. The results of our experiments support this hypothesis; after inhibition of myosin-actin interactions, the fibers produced virtually no active force but still increased the force after stretch.
A previous study has shown that rapid shortening imposed immediately before stretch of intact fibers from the frog decreases the force enhancement during and following activation (27) . If we assume that fiber shortening causes slackening of the passive element that would otherwise be responsible for force enhancement during stretch, the results of that study also corroborate our findings. Accordingly, the contribution of titin to the static tension and to the total force enhancement after stretch would uniquely depend on the length of the fiber upon activation and at the end of stretch.
Another mechanism by which Ca 2ϩ could increase the titin influence on the force production is by increasing the binding of titin with actin, which would increase the sarcomere stiffness. Early studies have shown that titin inhibited significantly the sliding of the actin filaments on in vitro motility essays in the presence of Ca 2ϩ , suggesting that titin binding to actin increases (15) . However, subsequent studies using recombinant titin fragments failed to detect binding between the tandem Ig segments of titin and actin (17, 35) , and Stuyvers et al. (32) observed that an increase in Ca 2ϩ concentration reduced rather than increased titin-actin interactions. Our results are consistent with these studies, because when we used gelsolin in fibers already treated for removal of troponin with rigor-EDTA and bathed in blebbistatin (ϩ/Ϫ), the static tension was still present, at levels similar to those observed before gelsolin treatment. Thus our results suggest that the increase in forces produced during stretch in the presence of Ca 2ϩ is caused entirely by titin.
The variance of the static tension data decreased significantly after removal of TnC and actin filaments. This result suggests that an active component present in the muscle fibers before inhibition of myosin-actin and titin-actin interactions may play a role in the static tension, causing larger levels of variability. We suggest that this component is connected to half-sarcomere dynamics, caused by small imbalances in force at the start of the stretch under full fiber activation. A recent study shows that the stretch-induced force enhancement of isolated sarcomeres has two components associated with 1) passive structures and 2) half-sarcomere length nonuniformities (31) . The latter may lead to different degrees of titin elongation and stiffness in varying sections of cells, increasing the variability of the passive contribution to the force enhancement.The mechanism would be exacerbated when high levels of force are produced (i.e., when myosin-actin interactions are present) causing movements of the thick filaments with resultant nonuniformities between half-sarcomeres. Since the variance of the static tension was not different between the two conditions in which the fibers were treated for removal of TnC or actin, the nonuniformity of half-sarcomeres is not likely associated with titin-actin interactions. Thus, although not directly responsible for the stretch-induced force enhancement, myosin-actin and actin-titin interactions may indirectly influence the static tension by causing larger degrees of halfsarcomere stretches in some regions of the fibers.
Regulation of the passive force-SL relation. We observed a small but significant upward shift in the passive force-SL relation in the fibers treated with rigor-EDTA and gelsolin when Ca 2ϩ was present. A similar result was observed before with permeabilized fibers from the rabbit (18) after removal of thin filament with gelsolin using a procedure similar to ours; the levels of increase in passive force are very similar. Interestingly, the passive force was increased both during and after the stretch, which suggests that the effects of Ca 2ϩ on titin are observed when the molecular spring are unveiled and then remain for a period of time, which would be associated with the residual static tension.
Although the increases that we observed were much smaller than those observed in a recent study with myofibrils (20) , they are still in the range published in most studies in the literature 5. An increase in Ca 2ϩ concentration caused an increase in forces produced by the fiber during and after stretch. B: passive force-SL relation for all fibers investigated in this study, before, and after treatment with rigor-EDTA, gelsolin, and blebbistatin (ϩ/Ϫ), in pCa 2ϩ 9 .0 (open symbols), and pCa 2ϩ 4.5 (closed symbols). Both the peak forces during the stretches (triangles, peak) and the passive forces after the stretches (circles, after) increase at pCa 2ϩ 4.5. (18, 30) . Leonard and Herzog (20) have observed that myofibrils stretched to Ͼ4.0 m (up to 6.0 m), where overlap between myosin-actin is absent, produce increases in force in the presence of Ca 2ϩ of extremely large magnitudes (Ͼ200% of maximal active force at optimal overlap). The authors suggest that, upon muscle activation (i.e., high Ca 2ϩ concentration), titin attaches to actin, shortening its length and increasing its resistance to stretch. The interaction between titin and actin would be modulated by active force or the number of attached cross bridges to actin. This modulation could occur through movements of regulatory proteins troponin and tropomyosin, which would expose titin attachment sites on actin, or through stretching of the actin filament, directly exposing titin attachment sites on actin. Our results with the TnC-depleted fibers and gelsolin-treated fibers are inconsistent with both mechanisms, as the static tension is still present in these conditions. Our results are consistent with studies that failed to detect an increased binding between the tandem Ig segments of titin and actin in the presence of Ca 2ϩ (16, 28) . It is possible that a mechanism incorporating a force-dependent titin-actin interaction may work in highly stretched myofibrils and fibers (e.g., Ref. 20) , but it did not play a role in our study because we never stretched fibers to lengths beyond 3.65 m.
Physiological implications. Although titin has been commonly associated with regulation of passive forces in skeletal muscles, the results of this study suggest that titin is also important during active force production. When muscles are activated, the increase in intracellular Ca 2ϩ concentration induces not only myosin-actin interactions and the development of active force but also an increase in titin stiffness. This Ca 2ϩ -induced increase in titin stiffness may have important physiological roles. First, it is well accepted that titin helps to maintain the thick filaments centralized during passive stretches (11) . The increased stiffness of titin during activation may be important to balance increasing forces in half-sarcomeres due to myosin-actin interactions, which might otherwise cause continuous movements of the thick filaments from the center of the sarcomeres. Second, it has been known that muscles that are stretched during activation produce a substantial increase in force without a concomitant increase in the energetic cost and ATP consumption (34) . Titin may be partly responsible for this force increase, as stiffer sarcomeres would produce more force without the need for extra ATP consumption. Third, an increase in titin stiffness may help in the prevention of stretch-induced injury in skeletal muscles. Fourth, Ca 2ϩ regulation of titin can provide a powerful mechanism for the stable behavior of sarcomeres when they are activated along the descending limb of the force-length relationship (24) . Finally, if a similar mechanism of Ca 2ϩ -regulated titin stiffness is shown in cardiac muscles, it would have profound implications for cardiac regulation (an issue to be investigated in future studies).
In summary, the static tension observed in previous studies, directly associated with the residual force enhancement, a phenomenon observed for more than 50 years, and yet without a clear explanation, did not vanish when fibers were treated for partial extraction of TnC and actin. The results suggest that the static tension is associated with the properties of titin, which may change its properties upon Ca 2ϩ activation; the mechanisms deserve further studies.
